These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3913605)

  • 21. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
    Kalafut F; Hung PM; Novotná L; Klobusická M
    Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
    Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
    Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A radio (111In) capillary tube leukocyte adherence inhibition assay for the detection of specific tumor-associated immunity.
    Peng R; Myers WL
    Immunol Commun; 1984; 13(4):293-303. PubMed ID: 6384031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
    Kubasova T; Pázmány T; Horváth M; Pál K; Köteles GJ
    Neoplasma; 1991; 38(1):63-8. PubMed ID: 2011211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte adherence inhibition as measured by a radioisotopic technique for detection of cell-mediated tumor immunity.
    Pierce GE; DeVald BL
    Int J Cancer; 1974 Dec; 14(6):833-9. PubMed ID: 4377009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
    Tataryn DN; MacFarlane JK; Murray D; Thomson DM
    Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of self and non-self tissue antigens in peripheral blood leucocytes from normal rats detected by the tube LAI assay.
    Vancatová A; Holán V; Hasek M
    Folia Biol (Praha); 1982; 28(5):363-7. PubMed ID: 6983461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte activation in advanced cancer as an explanation for absent leukocyte adherence inhibition to cancer extracts and chemoattractant.
    Labateya N; Thomson DM; Reid EC
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):33-43. PubMed ID: 3007156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
    Thomson DM; Halliday WJ; Phelan K
    J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
    Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
    J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
    Sanner T; Kotlar HK; Eker P
    Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
    Dubois AE; Thomson DM; Sutherland ME; Scanzano R
    Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen-specific leukocyte adherence inhibition (LAI) assay: sensitivity, specificity and mechanism.
    Fink A; Heller L; Eliraz A; Weisman Z; Miskin A; Schlezinger M; Bibi H; Bentwich Z
    Immunol Lett; 1987 Oct; 16(1):65-70. PubMed ID: 3323035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-mediated immune reactions directed against syngeneic methylcholanthrene-induced mouse sarcomas: low reproducibility of the results obtained with the tube modification of leukocyte adherence inhibition assay.
    Simová J; Bubeník J
    Neoplasma; 1979; 26(5):635-9. PubMed ID: 392326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.